M&T Bank Corp Sells 22,162 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

M&T Bank Corp decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 56.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,917 shares of the medical instruments supplier's stock after selling 22,162 shares during the quarter. M&T Bank Corp's holdings in DENTSPLY SIRONA were worth $321,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in XRAY. Riverview Trust Co acquired a new stake in DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB grew its position in DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock worth $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. grew its position in DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 564 shares in the last quarter. Venturi Wealth Management LLC grew its position in DENTSPLY SIRONA by 4,893.5% during the third quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier's stock worth $62,000 after buying an additional 2,251 shares in the last quarter. Finally, Brooklyn Investment Group acquired a new stake in DENTSPLY SIRONA during the third quarter worth approximately $77,000. Institutional investors and hedge funds own 95.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on XRAY. Morgan Stanley reduced their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research report on Tuesday, December 17th. UBS Group reduced their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Finally, Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $23.33.

Remove Ads

DENTSPLY SIRONA Trading Up 1.0 %

DENTSPLY SIRONA stock traded up $0.15 during trading hours on Tuesday, reaching $15.74. 2,288,980 shares of the company's stock were exchanged, compared to its average volume of 2,972,147. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm's 50 day simple moving average is $18.22 and its 200 day simple moving average is $20.81. DENTSPLY SIRONA Inc. has a twelve month low of $14.78 and a twelve month high of $33.72. The firm has a market capitalization of $3.13 billion, a PE ratio of -7.60, a PEG ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.07%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Insider Activity

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.52% of the stock is currently owned by company insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.